摘要
目的:比较静脉应用普罗帕酮和胺碘酮治疗阵发性心房颤动的效果。方法:本次实验以我院收治的80例阵发性心房颤动患者为实验对象,将患者随机分为普罗帕酮组和胺碘酮组两组,对比分析两组患者的临床治疗效果。结果:经过治疗,普罗帕酮组、胺碘酮组转复率分别为75%、80%,平均转复时间分别为(38.5±12.5)min、(49.2±13.5)min。结论:本次实验结果表明,普罗帕酮和胺碘酮都是较为有效的阵发性心房颤动临床治疗药物,但普罗帕酮在患者的转复率和转复时间方面显著优于胺碘酮。
Objective： To compare intravenous propafenone and amiodarone in the treatment of paroxysmal atrial fibrillation re- suits. Method： The method of this experiment to our hospital 80 patients with paroxysmal atrial fibrillation patients as experimental subjects, patieots were randomly divided into two groups of propafenone group and amiodarone group, compared to the clinical effect of the two groups were analyzed. Results： After treatment, propafenone group, amiodarone cardioversion rates were 75%, 80%, with an average time of cardioversion （38. 5 ± 12. 5） min, （49. 2 ±13.5） min. Conclusion： To discuss the experiment results show that propafenone and amiodarone is more effective paroxysmal atrial fibrillation therapy, propafenone in the cardioversion in patients with rate and time of cardioversion was significantly superior to amiodarone.
出处
《中国药物评价》
2012年第2期132-133,176,共3页
Chinese Journal of Drug Evaluation
关键词
普罗帕酮
胺碘酮
阵发性心房颤动
Propafenone
Amiodarone
Paroxysmal Atrial Fibrillation
